A Study of Setmelanotide in Patients With Prader-Willi Syndrome
Clinical trial NCT06772597 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06772597
- Sponsor
- Rhythm Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-04
- Primary completion
- 2026-10-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.